Assessing cognitive change in Parkinson's disease: Development of practice effect-corrected reliable change indices

Archives of Clinical Neuropsychology

Volumn 22, Issue 6, 2007, Pages 711-718

  Tröster, Alexander I ^a   Woods, Steven Paul ^b   Morgan, Erin E ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Dementia; Language; Memory; Neuropsychology; Parkinson's disease; Reliable change index

Indexed keywords

CHOLINESTERASE INHIBITOR;

ADULT; ARTICLE; BEHAVIOR CHANGE; BRAIN DEPTH STIMULATION; COGNITION; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROMODULATION; PARKINSON DISEASE; PSYCHOLOGIC TEST; TEST RETEST RELIABILITY; TREATMENT OUTCOME;

EID: 34548225369     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1016/j.acn.2007.05.004     Document Type: Article

References (36)

1. Aarsland D., Andersen K., Larsen J.P., Perry R., Wentzel-Larsen T., Lolk A., et al. The rate of cognitive decline in Parkinson disease. Archives of Neurology 61 (2004) 1906-1911
2. Aarsland D., Mosimann U.P., and McKeith I.G. Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies. Journal of Geriatric Psychiatry & Neurology 17 (2004) 164-171
3. Aarsland D., Zaccai J., and Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Movement Disorders 20 (2005) 1255-1263
4. Azuma T., Cruz R.F., Bayles K.A., Tomoeda C.K., and Montgomery E.B. A longitudinal study of neuropsychological change in individuals with Parkinson's disease. International Journal of Geriatric Psychiatry 18 (2003) 1043-1049
5. Basso M.R., Bornstein R.A., and Lang J.M. Practice effects on commonly used measures of executive function across twelve months. The Clinical Neuropsychologist 13 (1999) 283-292
6. Beck A.T., and Steer R.A. Beck Depression Inventory manual (1993), Psychological Corporation, New York
7. Bedard M.A., Pillon B., Dubois B., Duchesne N., Masson H., and Agid Y. Acute and long-term administration of anticholinergics in Parkinson's disease: Specific effects on the subcortico-frontal syndrome. Brain and. Cognition 40 (1999) 289-313
8. Benton A.L., Hamsher K., and Sivan A.B. Multilingual Aphasia Examination (1994), AJA Associates, Iowa City
9. Brusa L., Bassi A., Stefani A., Pierantozzi M., Peppe A., Caramia M.D., et al. Pramipexole in comparison to l-dopa: A neuropsychological study. Journal of Neural Transmission 110 (2003) 373-380
10. Chelune G.J., Naugle R.I., Lüders H., Sedlack J., and Awad I.A. Individual change after epilepsy surgery: Practice effects and base-rate information. Neuropsychology 7 (1993) 41-52
11. Cools R., Stefanova E., Barker R.A., Robbins T.W., and Owen A.M. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125 (2002) 584-594
12. Delis D.C., Kramer J., Kaplan E., and Ober B.A. California Verbal Learning Test (CVLT) manual (1987), Psychological Corporation, San Antonio, TX
13. Foltynie T., Brayne C.E., Robbins T.W., and Barker R.A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127 (2004) 550-560
14. Growdon J.H., et al. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Neurology 50 (1998) 1327-1331
15. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., and Curtiss G. Wisconsin Card Sorting Test manual (1993), Psychological Assessment Resources, Odessa, FL
16. Heaton R.K., Temkin N., Dikmen S., Avitable N., Taylor M.J., Marcotte T.D., et al. Detecting change: A comparison of three neuropsychological methods, using normal and clinical samples. Archives of Clinical Neuropsychology 16 (2001) 75-91
17. Huizenga H.M., Smeding H., Grasman R.P., and Schmand B. Multivariate normative comparisons. Neuropsychologia 45 (2007) 2534-2542
18. Jacobson N.S., and Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59 (1991) 12-19
19. Kaplan E., Goodglass H., and Weintraub S. The Boston Naming Test (1983), Lea and Febiger, Philadelphia
20. Kieburtz K., McDermott M., Como P., Growdon J., Brady J., Carter J., et al. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Neurology 44 (1994) 1756-1759
21. Koller W.C. Disturbance of recent memory function in parkinsonian patients on anticholinergic therapy. Cortex 20 (1984) 307-311
22. Kulisevsky J., Garcia-Sanchez C., Berthier M.L., Barbanoj M., Pascual-Sedano B., Gironell A., et al. Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two-year follow-up study of previously untreated patients. Movement Disorders 15 (2000) 613-626
23. Lewis M.S., Maruff P., Silbert B.S., Evered L.A., and Scott D.A. The influence of different error estimates in the detection of post-operative cognitive dysfunction using reliable change indices with correction for practice effects. Archives of Clinical Neuropsychology 21 (2006) 421-427
24. Mattis S. Dementia Rating Scale (DRS) (1988), Psychological Assessment Resources, Odessa, FL
25. McCaffrey R.J., Duff K., and Westervelt H.J. Practitioner's guide to evaluating change with neuropsychological assessment instruments (2000), Kluwer Academic/Plenum Publishers, New York
26. McSweeney A.J., Naugle R.I., Chelune G.J., and Lüders H. "T scores for change:" An illustration of a regression approach to depicting change in clinical neuropsychology. The Clinical Neuropsychologist 7 (1993) 300-312
27. Muslimovic D., Post B., Speelman J.D., and Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65 (2005) 1239-1245
28. Parsons T.D., Rogers S.A., Braaten A.J., Woods S.P., and Tröster A.I. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: A meta-analysis. Lancet Neurology 5 (2006) 578-588
29. Rabin L.A., Barr W.B., and Burton L.A. Assessment practices of clinical neuropsychologists in the United States and Canada: A survey of INS, NAN, and APA Division 40 members. Archives of Clinical Neuropsychology 20 (2005) 33-65
30. Schmand B., de Bie R.M., Koning-Haanstra M., de Smet J.S., Speelman J.D., and van Zomeren A.H. Unilateral pallidotomy in PD: A controlled study of cognitive and behavioral effects. The Netherlands Pallidotomy Study (NEPAS) group. Neurology 54 (2000) 1058-1064
31. Temkin N.R., Heaton R.K., Grant I., and Dikmen S.S. Detecting significant change in neuropsychological test performance: A comparison of four models. Journal of the International Neuropsychological Society 5 (1999) 357-369
32. Tröster A.I. Clinical neuropsychology, functional neurosurgery, and restorative neurology in the next millennium: Beyond secondary outcome measures. Brain and Cognition 42 (2000) 117-119
33. Wechsler D. Wechsler Adult Intelligence Scale-Revised manual (1981), The Psychological Corporation, New York
34. Wechsler D. Wechsler Memory Scale-Revised manual (1987), The Psychological Corporation, San Antonio, TX
35. Woods S.P., Childers M., Ellis R.J., Guaman S., Grant I., Heaton R.K., et al. A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology 21 (2006) 83-89
36. Woods S.P., and Tröster A.I. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. Journal of the International Neuropsychological Society 9 (2003) 17-24